1. Academic Validation
  2. Implications of glutathione-S transferase P1 in MAPK signaling as a CRAF chaperone: In memory of Dr. Irving Listowsky

Implications of glutathione-S transferase P1 in MAPK signaling as a CRAF chaperone: In memory of Dr. Irving Listowsky

  • Proc Jpn Acad Ser B Phys Biol Sci. 2022;98(2):72-86. doi: 10.2183/pjab.98.005.
Yoshiro Niitsu 1 2 Yasushi Sato 3 Tetsuji Takayama 3
Affiliations

Affiliations

  • 1 Oncology Section, Center of Advanced Medicine, Shonan Kamakura Innovation Park, Shonan Kamakura General Hospital.
  • 2 Sapporo Medical University.
  • 3 Department of Community Medicine for Gastroenterology and Oncology, Tokushima University Graduate School of Biomedical Sciences.
Abstract

Glutathione-S transferase P1 (GSTP1) is one of the glutathione-S transferase isozymes that belong to a family of phase II metabolic isozymes. The unique feature of GSTP1 compared with Other GST isozymes is its relatively high expression in malignant tissues. Thus, clinically, GSTP1 serves as a tumor marker and as a refractory factor against certain types of Anticancer drugs through its primary function as a detoxifying enzyme. Additionally, recent studies have identified a chaperone activity of GSTP1 involved in the regulation the function of various intracellular proteins, including factors of the growth signaling pathway. In this review, we will first describe the function of GSTP1 and then extend the details onto its role in the mitogen-activated protein kinase signal pathway, referring to the results of our recent study that proposed a novel autocrine signal loop formed by the CRAF/GSTP1 complex in mutated KRAS and BRAF cancers. Finally, the possibilities of new therapeutic approaches for these cancers by targeting this complex will be discussed.

Keywords

BRAF cancer; GSTP1; KRAS cancer; MAPK signaling; drug resistance; tumor marker.

Figures
Products